EconPapers    
Economics at your fingertips  
 

A metabolite-derived protein modification integrates glycolysis with KEAP1–NRF2 signalling

Michael J. Bollong, Gihoon Lee, John S. Coukos, Hwayoung Yun, Claudio Zambaldo, Jae Won Chang, Emily N. Chin, Insha Ahmad, Arnab K. Chatterjee, Luke L. Lairson (), Peter G. Schultz () and Raymond E. Moellering ()
Additional contact information
Michael J. Bollong: The Scripps Research Institute
Gihoon Lee: University of Chicago
John S. Coukos: University of Chicago
Hwayoung Yun: The Scripps Research Institute
Claudio Zambaldo: The Scripps Research Institute
Jae Won Chang: University of Chicago
Emily N. Chin: The Scripps Research Institute
Insha Ahmad: The Scripps Research Institute
Arnab K. Chatterjee: California Institute for Biomedical Research (Calibr)
Luke L. Lairson: The Scripps Research Institute
Peter G. Schultz: The Scripps Research Institute
Raymond E. Moellering: University of Chicago

Nature, 2018, vol. 562, issue 7728, 600-604

Abstract: Abstract Mechanisms that integrate the metabolic state of a cell with regulatory pathways are necessary to maintain cellular homeostasis. Endogenous, intrinsically reactive metabolites can form functional, covalent modifications on proteins without the aid of enzymes1,2, and regulate cellular functions such as metabolism3–5 and transcription6. An important ‘sensor’ protein that captures specific metabolic information and transforms it into an appropriate response is KEAP1, which contains reactive cysteine residues that collectively act as an electrophile sensor tuned to respond to reactive species resulting from endogenous and xenobiotic molecules. Covalent modification of KEAP1 results in reduced ubiquitination and the accumulation of NRF27,8, which then initiates the transcription of cytoprotective genes at antioxidant-response element loci. Here we identify a small-molecule inhibitor of the glycolytic enzyme PGK1, and reveal a direct link between glycolysis and NRF2 signalling. Inhibition of PGK1 results in accumulation of the reactive metabolite methylglyoxal, which selectively modifies KEAP1 to form a methylimidazole crosslink between proximal cysteine and arginine residues (MICA). This posttranslational modification results in the dimerization of KEAP1, the accumulation of NRF2 and activation of the NRF2 transcriptional program. These results demonstrate the existence of direct inter-pathway communication between glycolysis and the KEAP1–NRF2 transcriptional axis, provide insight into the metabolic regulation of the cellular stress response, and suggest a therapeutic strategy for controlling the cytoprotective antioxidant response in several human diseases.

Keywords: Keap1-Nrf2 Signaling; Phosphoglycerate Kinase (PGK1); Glycolytic Enzyme PGK1; Methylglyoxal; Stable Isotope Labeling With Amino Acids In Cell Culture (SILAC) (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-018-0622-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:562:y:2018:i:7728:d:10.1038_s41586-018-0622-0

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-018-0622-0

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:562:y:2018:i:7728:d:10.1038_s41586-018-0622-0